Ms Rachel Morrogh:

To quickly answer the question as to how the national cancer strategy is progressing, an interim report was recently published. The Deputy may be aware of this report. Of the strategy's 23 key performance indicators, 14 expired between 2017 and 2020. Of the 14 targets associated with deadlines, there were no data available on eight. That highlights what colleagues have said with regard to the lack of data. How can we expect good-quality progress and real change for patients when we cannot even measure what it is we are meant to be doing? We are now five years into a ten-year strategy. The fact that there are no data available for eight key performance indicators that have expired is pretty revealing.